Fig. 7
From: Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
Analysis of differences in pathway activation and gene expression between risk groups. A Wilcoxon signed-rank test results of 14 typical pathway activation scores between high- and low-risk groups. B volcano plot of DEGs. C Pathway analysis results based on Metascape. D, E The mutation landscape of patients in the TCGA-PDAC cohort (show the top 20 genes) about the high- and low-risk groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)